Archit Organosys Share Price
Sector: Chemical Manufacturing
43.65 +1.22 (2.88%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
42.26
Today’s High
44.00
52 Week Low
34.20
52 Week High
61.00
Key Metrics
- Market Cap (In Cr) 88.39
- Beta 0.7
- Div. Yield (%) 1.15
- P/B 1.3
- TTM P/E 15.2
- Sector P/E 17.63
- D/E 0
- Open Price 42.26
- Prev Close 42.43
Archit Organosys Analysis
Price Analysis
-
1 Week3.29%
-
3 Months16.74%
-
6 Month-9.35%
-
YTD-8.61%
-
1 Year-18.9%
Risk Meter
- 54% Low risk
- 54% Moderate risk
- 54% Balanced Risk
- 54% High risk
- 54% Extreme risk
Archit Organosys Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 125.6
- Selling/ General/ Admin Expenses Total
- 7.1
- Depreciation/ Amortization
- 5.94
- Other Operating Expenses Total
- 16.19
- Total Operating Expense
- 118.57
- Operating Income
- 7.03
- Net Income Before Taxes
- 7.54
- Net Income
- 5.05
- Diluted Normalized EPS
- 2.46
- Period
- 2025
- Total Assets
- 122.92
- Total Liabilities
- 53.71
- Total Equity
- 69.21
- Tangible Book Valueper Share Common Eq
- 33.65
- Period
- 2025
- Cashfrom Operating Activities
- 18.52
- Cashfrom Investing Activities
- -20.85
- Cashfrom Financing Activities
- -1.43
- Net Changein Cash
- -3.75
- Period
- 2024
- Total Revenue
- 113.19
- Selling/ General/ Admin Expenses Total
- 11.18
- Depreciation/ Amortization
- 5.66
- Other Operating Expenses Total
- 10.93
- Total Operating Expense
- 114.5
- Operating Income
- -1.3
- Net Income Before Taxes
- 4.32
- Net Income
- 3.28
- Diluted Normalized EPS
- 0.39
- Period
- 2024
- Total Assets
- 108.24
- Total Liabilities
- 44.09
- Total Equity
- 64.15
- Tangible Book Valueper Share Common Eq
- 31.19
- Period
- 2024
- Cashfrom Operating Activities
- 10.1
- Cashfrom Investing Activities
- -2.16
- Cashfrom Financing Activities
- -9.13
- Net Changein Cash
- -1.2
- Period
- 2023
- Total Revenue
- 127.78
- Selling/ General/ Admin Expenses Total
- 7.37
- Depreciation/ Amortization
- 4.83
- Other Operating Expenses Total
- 18.25
- Total Operating Expense
- 111.44
- Operating Income
- 16.34
- Net Income Before Taxes
- 15.37
- Net Income
- 11.36
- Diluted Normalized EPS
- 4.91
- Period
- 2023
- Total Assets
- 120.17
- Total Liabilities
- 58.4
- Total Equity
- 61.78
- Tangible Book Valueper Share Common Eq
- 30.04
- Period
- 2023
- Cashfrom Operating Activities
- 17.24
- Cashfrom Investing Activities
- -10.7
- Cashfrom Financing Activities
- -6.57
- Net Changein Cash
- -0.03
- Period
- 2022
- Total Revenue
- 136.66
- Selling/ General/ Admin Expenses Total
- 6.51
- Depreciation/ Amortization
- 4.69
- Other Operating Expenses Total
- 12.58
- Total Operating Expense
- 124.24
- Operating Income
- 12.43
- Net Income Before Taxes
- 11.43
- Net Income
- 8.23
- Diluted Normalized EPS
- 4.18
- Period
- 2022
- Total Assets
- 103.55
- Total Liabilities
- 51.66
- Total Equity
- 51.89
- Tangible Book Valueper Share Common Eq
- 25.29
- Period
- 2022
- Cashfrom Operating Activities
- 10.62
- Cashfrom Investing Activities
- -11.52
- Cashfrom Financing Activities
- 2.43
- Net Changein Cash
- 1.54
- Period
- 2021
- Total Revenue
- 94.51
- Selling/ General/ Admin Expenses Total
- 6.1
- Depreciation/ Amortization
- 3.67
- Other Operating Expenses Total
- 12.42
- Total Operating Expense
- 86.89
- Operating Income
- 7.62
- Net Income Before Taxes
- 4.68
- Net Income
- 5.01
- Diluted Normalized EPS
- 3.43
- Period
- 2021
- Total Assets
- 87.49
- Total Liabilities
- 46.95
- Total Equity
- 40.54
- Tangible Book Valueper Share Common Eq
- 26.99
- Period
- 2021
- Cashfrom Operating Activities
- 11.11
- Cashfrom Investing Activities
- -2.87
- Cashfrom Financing Activities
- -7.38
- Net Changein Cash
- 0.86
- Period
- 2020
- Total Revenue
- 76.69
- Selling/ General/ Admin Expenses Total
- 6.17
- Depreciation/ Amortization
- 3.47
- Other Operating Expenses Total
- 9.73
- Total Operating Expense
- 76.55
- Operating Income
- 0.14
- Net Income Before Taxes
- -0.79
- Net Income
- -0.8
- Diluted Normalized EPS
- -0.53
- Period
- 2020
- Total Assets
- 83.17
- Total Liabilities
- 49.06
- Total Equity
- 34.11
- Tangible Book Valueper Share Common Eq
- 22.69
- Period
- 2020
- Cashfrom Operating Activities
- 7.79
- Cashfrom Investing Activities
- -0.87
- Cashfrom Financing Activities
- -8.87
- Net Changein Cash
- -1.95
- Period
- 2019
- Total Revenue
- 84
- Selling/ General/ Admin Expenses Total
- 5.36
- Depreciation/ Amortization
- 2.79
- Other Operating Expenses Total
- 8.09
- Total Operating Expense
- 89.67
- Operating Income
- -5.68
- Net Income Before Taxes
- -6.26
- Net Income
- -4.72
- Diluted Normalized EPS
- -3.2
- Period
- 2019
- Total Assets
- 84.11
- Total Liabilities
- 49.19
- Total Equity
- 34.92
- Tangible Book Valueper Share Common Eq
- 23.22
- Period
- 2019
- Cashfrom Operating Activities
- 2.75
- Cashfrom Investing Activities
- 1.06
- Cashfrom Financing Activities
- 0.36
- Net Changein Cash
- 4.16
- Period
- 2025-03-31
- Total Revenue
- 43.18
- Selling/ General/ Admin Expenses Total
- 1.86
- Depreciation/ Amortization
- 1.46
- Other Operating Expenses Total
- 5.26
- Total Operating Expense
- 40.23
- Operating Income
- 2.95
- Net Income Before Taxes
- 3.31
- Net Income
- 2.02
- Diluted Normalized EPS
- 0.98
- Period
- 2025-03-31
- Total Assets
- 122.92
- Total Liabilities
- 53.71
- Total Equity
- 69.21
- Tangible Book Valueper Share Common Eq
- 33.65
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 18.52
- Cashfrom Investing Activities
- -20.85
- Cashfrom Financing Activities
- -1.43
- Net Changein Cash
- -3.75
- Period
- 2024-12-31
- Total Revenue
- 25.87
- Selling/ General/ Admin Expenses Total
- 2.16
- Depreciation/ Amortization
- 1.49
- Other Operating Expenses Total
- 4.25
- Total Operating Expense
- 24.71
- Operating Income
- 1.16
- Net Income Before Taxes
- 1.63
- Net Income
- 1.01
- Diluted Normalized EPS
- 0.49
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 29.54
- Selling/ General/ Admin Expenses Total
- 2.48
- Depreciation/ Amortization
- 1.5
- Other Operating Expenses Total
- 1.9
- Total Operating Expense
- 28.19
- Operating Income
- 1.35
- Net Income Before Taxes
- 1.2
- Net Income
- 1.02
- Diluted Normalized EPS
- 0.5
- Period
- 2024-09-30
- Total Assets
- 117.51
- Total Liabilities
- 51.34
- Total Equity
- 66.17
- Tangible Book Valueper Share Common Eq
- 32.18
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 3.63
- Cashfrom Investing Activities
- -10.45
- Cashfrom Financing Activities
- 3.05
- Net Changein Cash
- -3.77
- Period
- 2024-06-30
- Total Revenue
- 27
- Selling/ General/ Admin Expenses Total
- 1.96
- Depreciation/ Amortization
- 1.49
- Other Operating Expenses Total
- 3.43
- Total Operating Expense
- 25.44
- Operating Income
- 1.56
- Net Income Before Taxes
- 1.41
- Net Income
- 1.01
- Diluted Normalized EPS
- 0.49
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 30.99
- Selling/ General/ Admin Expenses Total
- 2.03
- Depreciation/ Amortization
- 1.49
- Other Operating Expenses Total
- 8.96
- Total Operating Expense
- 28.82
- Operating Income
- 2.17
- Net Income Before Taxes
- 2.28
- Net Income
- 1.79
- Diluted Normalized EPS
- -0.2
- Period
- 2024-03-31
- Total Assets
- 108.24
- Total Liabilities
- 44.09
- Total Equity
- 64.15
- Tangible Book Valueper Share Common Eq
- 31.19
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 10.1
- Cashfrom Investing Activities
- -2.16
- Cashfrom Financing Activities
- -9.13
- Net Changein Cash
- -1.2
- Period
- 2023-12-31
- Total Revenue
- 24.81
- Selling/ General/ Admin Expenses Total
- 2.05
- Depreciation/ Amortization
- 1.49
- Other Operating Expenses Total
- 3.25
- Total Operating Expense
- 25.2
- Operating Income
- -0.39
- Net Income Before Taxes
- -0.64
- Net Income
- -0.46
- Diluted Normalized EPS
- -0.22
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Archit Organosys Technical
Moving Average
SMA
- 5 Day42.79
- 10 Day43.33
- 20 Day43.93
- 50 Day42.06
- 100 Day41.07
- 300 Day43.65
Archit Organosys Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Daikaffil Chemicals India
- 161.7
- 2.65
- 1.67
- 281
- 104.01
- 97.02
- Retina Paints
- 59.25
- 2.36
- 4.15
- 97.5
- 40
- 90.89
- Archit Organosys
- 43.65
- 1.22
- 2.88
- 61
- 34.2
- 88.39
- Aeonx Digital Technology
- 183.9
- -6.1
- -3.21
- 323.3
- 108
- 84.63
- Indra Industries
- 15.23
- 0.29
- 1.94
- 20.07
- 5.62
- 83.85
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Daikaffil Chemicals India
- -
- 10.58
- -10.6
- -30.82
- Retina Paints
- 69.7
- 2.66
- 4.6
- 4.44
- Archit Organosys
- 17.74
- 1.3
- 12.19
- 5.51
- Aeonx Digital Technology
- 21.02
- 1.65
- 6.23
- 10.1
- Indra Industries
- 5.44
- -
- -
- -
Archit Organosys Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 23-May-25
- Audited Results & Dividend
- 14-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 30-May-24
- Audited Results & Final Dividend
- 14-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 12-May-23
- Audited Results & Final Dividend
- 13-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 09-Sept-24
- 08-Aug-24
- AGM
- 31-Aug-23
- 09-Aug-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-25
- -
- -
- 0.5
- 12-May-23
- -
- 08-Aug-23
- 0.5
- 12-May-22
- -
- 24-Aug-22
- 0.75
- 14-Jun-21
- -
- 02-Sept-21
- 0.5


